0.40Open0.40Pre Close0 Volume16 Open Interest18.00Strike Price0.00Turnover4644.22%IV4.66%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type0.3917Delta0.2529Gamma43.95Leverage Ratio-234.5387Theta0.0000Rho17.22Eff Leverage0.0001Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet